FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers
Ann Neurol 92:337-339, Koizumi, N.,et al, 2022
FDG-PET a Pivotal Imaging Modality for Diagnosis of Stroke-Onset Intravascular Lymphoma
Arch Neurol 67:366-367, Yamada,S.,et al, 2010
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Silent Brain Infarction in Nonrheumatic Atrial Fibrillation
EAFT Study Group, Neurol 46:159-1651996., , 1996
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Recurrent Embolic Stroke and Cocaine-Related Cardiomyopathy
Stroke 22:1203-1205, Sauer,C.M., 1991
Myxoma of the Heart Presenting with Recurrent Episodes of Hemorrhagic Cerebral Infarction:MR Findings
J Comput Assist Tomogr 13:123-125, Michael,A.S., 1989
Cerebrovascular Disease & Antiphospholipis Antibodies in SLE, Lupus-Like Dis, & Primary Antiphospholipid Synd
Am J Med 86:391-399, Asherson,R.A.,et al, 1989
Clinicopath Conf
Antiphospholipid-Antibody Syndrome, ANA-Negative Systemic Lupus Erythematosus, Case Study 37-1988, N, JM :699-712,1988., 1988
Embolic Stroke From Cardiac Papillary Fibroelastomas
Stroke 19:1171-1173, Kasarskis,E.J.,et al, 1988
Neurologic Manifestations of Atrial Myxoma, A 12-Year Experience and Review
Stroke 19:1435-1440, Knepper,L.E.,et al, 1988
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke
Stroke 53:1759-1763, Buckley, B.J.R.,et al, 2022
Case Report of Lambl Excrescences in a Pediatric Patient with Multifocal Strokes
Neurol 99:73-76, Robertson, D.M.,et al, 2022
Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
NEJM 382:9-19,81, Amarenco, P.,et al, 2020
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Recurrent Cerebral Ischemia During Pregnancies
Neurol 95:e2453-e2457, Bulwa, Z.,et al, 2020
Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke
Ann Neurol 88:946-955, Triantafyllou, S.,et al, 2020
A 62-year-old man with history of catheter ablation presenting with recurrent strokes
Neurol 95:e3065-e3069, Jeanneret, V.,et al, 2020
Ischemic Stroke and Internal Carotid Artery Web
Stroke 50:e31-e34, Mc Grory, B.,et al, 2019
Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
BMJ 360:k1717, Adderley, N.J.,et al, 2018
A 45-year-old Woman with Right Limb Weakness
Neurol 88:e103-e107, Li, S.,et al, 2017
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017
Cryptogenic Stroke
NEJM 374:2065-2074, Saver, J.L., 2016
Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack
Stroke 47:e188-e189, Li, J.,et al, 2016
Lambls Excrescense Associated with Cryptogenic Stroke
Am J Case Rep 16:876-881, Chu, A.,et al, 2015
Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014
Calcified Cerebral Emboli, A "Do Not Miss" Imaging Diagnosis: 22 New Cases and Review of the Literature
AJNR 35:1515-1519, Walker, B.S.,et al, 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Stroke Recurrence in Children with Congenital Heart Disease
Ann Neurol 72:103-111, Rodan, L.,et al, 2012
Atrial Myxoma
MedLink July, Muengtaweepongsa, S.,et al, 2011
Childhood Posterior Circulation Arterial Ischemic Stroke
Stroke 41:2201-2209, Mackay,M.T.,et al, 2010
Recurrent Ischemic Events in Young Adults After First-Ever Ischemic Stroke
Ann Neurol 68:661-671, Putaala,J.,et al, 2010
Clinicopath Conf, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NEJM 360:1656-1665, Case 12-2009, 2009
Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009
Recurrent Stroke and Massive Right-to-Left Shunt: Results from the Prospective Spanish Multicenter (CODICIA) Study
Stroke 39:3131-3136, Serena,J.,et al, 2008
Embolic Stroke Secondary to Cardiac Papillary Fibroelastoma
Neurologist 14:128-130, Zurru, M.C.,et al, 2008
Readmission and Death After Hospitalization for Acute Ischemic Stroke. 5-Year Follow-Up in the Medicare Population
Stroke 38:1899-1904, Bravata,D.M.,et al, 2007
Primary Systemic Amyloidosis With Ischemic Stroke as a Presenting Complication
Neurol 69:1136-1141, Yubkov,A.Y.,et al, 2007
Sinus Venous-Type Atrial Septal Defect: A Rare Curable Cause of Recurrent Transient Neurological Deficits
Stroke 37:2385-2386, Cakmak,S.,et al, 2006
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004